Cargando…
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants
Genetic factors such as the HLA type of patients may play a role in regard to disease severity and clinical outcome of patients with COVID-19. Taking the data deposited in the GISAID database, we made predictions using the IEDB analysis resource (TepiTool) to gauge how variants in the SARS-CoV-2 gen...
Autores principales: | de Sousa, Eric, Ligeiro, Dário, Lérias, Joana R., Zhang, Chao, Agrati, Chiara, Osman, Mohamed, El-Kafrawy, Sherif A., Azhar, Esam I., Ippolito, Giuseppe, Wang, Fu-Sheng, Zumla, Alimuddin, Maeurer, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368421/ https://www.ncbi.nlm.nih.gov/pubmed/32693089 http://dx.doi.org/10.1016/j.ijid.2020.07.016 |
Ejemplares similares
-
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies
por: Zumla, Alimuddin, et al.
Publicado: (2020) -
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies
por: Lérias, Joana R., et al.
Publicado: (2020) -
Reducing mortality from 2019-nCoV: host-directed therapies should be an option
por: Zumla, Alimuddin, et al.
Publicado: (2020) -
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
por: Lérias, Joana R., et al.
Publicado: (2020) -
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
por: Ramalho, Renata, et al.
Publicado: (2020)